A Vidal-Jordana, X Montalban - Neuroimaging Clinics, 2017 - neuroimaging.theclinics.com
Multiplesclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) in which inflammation, demyelination, and axonal loss occurs from the very early stages of …
S Klineova, FD Lublin - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
… multiplesclerosis (MS) subtypes, based solely on clinical … identified clinicalaspects of MS. As a result, potential new disease phenotypes, radiologically isolated syndrome, and clinically …
R Dobson, G Giovannoni - European journal of neurology, 2019 - Wiley Online Library
… Multiplesclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. … are discussed, before moving on to clinicalaspects of MS diagnosis and management. …
J Sastre-Garriga, D Pareto… - Neuroimaging …, 2017 - neuroimaging.theclinics.com
The neurodegenerative nature of multiplesclerosis (MS) was reappraised in 2 studies published in the late 1990s, in which an immediate connection between the inflammatory process …
I Lazibat, M Rubinić-Majdak, S Županić - Acta Clinica Croatica, 2018 - ncbi.nlm.nih.gov
… Pathogenesis of MultipleSclerosisMultiplesclerosis (MS) is an idiopathic chronic inflammatory demyelinating disease of the central nervous system (CNS) the leading features of which …
W Geidl, C Gobster, R Streber, K Pfeifer - Multiple sclerosis and related …, 2018 - Elsevier
… In the trip database, the term “multiplesclerosis guideline” was … as “multiplesclerosis” and “multiplesclerosis guidelines were … as “multiplesclerosis” and “multiplesclerosis guidelines …
… multiplesclerosis (MS) and related disorders, addressing the latest developments in management, treatment, and diagnostic technologies. Multiplesclerosis is … on multiplesclerosis …
LE Baldassari, JW Rose - Neurotherapeutics, 2017 - Elsevier
… daclizumab have demonstrated clinical efficacy in the treatment of multiplesclerosis. The … Drug Administration for relapsing-remitting multiplesclerosis, and is now formally termed …
… clinicalaspects of the disease.There is a drive to eliminate uncommon classification categories, such as PRMS; however, an ongoing dilemma with redefining MS phenotypes is the …